{
    "code": "02020742",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02020742",
    "time": "2020-02-25 12:31:53",
    "許可證字號": "衛署藥輸字第020742號",
    "註銷狀態": "已註銷",
    "註銷日期": "102\/12\/16",
    "註銷理由": "許可證已逾有效期",
    "製造許可登錄編號": "",
    "有效日期": "99\/01\/16",
    "發證日期": "84\/01\/16",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202074200",
    "中文品名": "貴舒醇－輕型懸液用粉劑",
    "英文品名": "QUESTRAN LITE",
    "適應症": "原發性高膽固醇血症；伴隨膽道阻塞之癢症；迴腸切除局部性迴陽炎、切除迷走神經、糖尿病迷走神經性病變所致之腹瀉；輻射線所致之腹瀉",
    "劑型": "141懸液用粉劑",
    "包裝": "盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "CHOLESTYRAMINE (CHOLESTYRAMINE RESIN)",
    "限制項目": "02輸　入",
    "申請商名稱": "1404501100  臺灣必治妥施貴寶股份有限公司",
    "申請商地址": "台北市松山區健康路156號4樓、5樓、6樓",
    "主製造廠": [
        {
            "製造廠名稱": "FAU0008000  BRISTOL-MYERS SQUIBB AUSTRALIA PTY. LTD.",
            "製造廠廠址": "556 PRINCES HIGHWAY NOBEL PARK VICTORIA 3174",
            "製造廠公司地址": "",
            "製造廠國別": "AUSTRALIA",
            "製程": ""
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2406000200",
            "成分名稱": "CHOLESTYRAMINE (CHOLESTYRAMINE RESIN)",
            "含量描述": "4.4",
            "含量": "4.4000000000",
            "單位": "GM"
        }
    ],
    "仿單外盒": [
        {
            "title": "020207420001.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02020742&Seq=001&Type=9"
        }
    ]
}